Realcan Pharmaceutical Group Co.Ltd(002589)
Independent directors’ opinions on relevant matters of the 18th meeting of the 4th board of directors
Prior approval of
As an independent director of Realcan Pharmaceutical Group Co.Ltd(002589) (hereinafter referred to as “the company”), in accordance with the stock listing rules of Shenzhen Stock Exchange (revised in 2022), the guiding opinions on the establishment of independent director system in listed companies and other relevant laws and regulations, as well as the relevant provisions of the company’s independent director working system, based on the principle of prudence and independent judgment, The prior approval opinions on the relevant matters considered at the 18th meeting of the Fourth Board of directors are as follows: I. prior approval opinions on the renewal of the accounting firm
After verification, we believe that tianyuanquan Certified Public Accountants (special general partnership) has the experience and ability to provide audit services for listed companies and can meet the quality requirements of the company’s audit work in 2021. The renewal of tianyuanquan Certified Public Accountants (special general partnership) is conducive to ensuring and improving the quality of the audit work of listed companies, It is conducive to protecting the interests of listed companies and other shareholders, especially the interests of minority shareholders.
Therefore, we agree to renew the appointment of tianyuanquan Certified Public Accountants (special general partnership) as the company’s audit institution in 2021 and submit it to the 18th meeting of the Fourth Board of directors for deliberation.
(there is no text on this page, which is the signature page of Realcan Pharmaceutical Group Co.Ltd(002589) independent directors’ prior approval opinions on matters related to the 18th meeting of the Fourth Board of directors) independent directors:
Wu binliu Xijun Yu Jianqing
January 21, 2021
